-
The AIDS Healthcare Foundation (AHF) commends Johnson & Johnson (J&J) for developing a pill that has shown promising results in a small trial for protecting against dengue fever and urges the company to ensure the treatment is accessible and affordable globally if it is eventually approved for public use.“J&J’s treatment for dengue fever could not come at a better time as the virus is affecting many countries, especially here in Peru where AHF staff have been affected,” said Dr. Jose Luis Sebast
-
Recap of CSR stories on Business Wire
-
J&J Green Paper and Sintesa Group join forces to produce eco-friendly paper coating, replacing plastic waste.
-
In an effort to address bias, hate, and discrimination within the United States, KERV Interactive (KERV), the leading AI-powered digital advertising platform, and the Ad Council, a national nonprofit organization at the forefront of driving change through social impact marketing, partnered to extend the Ad Council’s iconic Love Has No Labels campaign. Utilizing interactive technology to create opportunities for viewers to take meaningful action, the campaign partnership resulted in an overall cl
-
On Maternal Health Awareness Day, Walmart, J&J Consumer Health and CareSource announce an all-new program to support Black maternal health across Georgia
-
AHF is encouraged by President Biden’s announcements regarding global vaccination but cautions dramatic, game changing action is required to vaccinate our world
-
Council Members Announce Measurable Actions Their Organizations Are Taking To Create a More Inclusive Economy
-
The Papa John’s Foundation for Building Community Awards Grants to Bennett College, the Boys & Girls Clubs of America and the Association of American Colleges & Universities